Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Unknown 3

Sponsor Class

OTHER 3NIH 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Breast Neoplasms 26Colorectal Neoplasms 17Colonic Neoplasms 15Central Nervous System Neoplasms 15Rectal Neoplasms 11Glioblastoma 7Lung Neoplasms 6Kidney Neoplasms 6Gliosarcoma 6Carcinoma, Non-Small-Cell Lung 6Brain Neoplasms 6Astrocytoma 6Ovarian Neoplasms 5Liver Neoplasms 5Head and Neck Neoplasms 5Carcinoma, Renal Cell 5Carcinoma, Ovarian Epithelial 5Sarcoma 4Neoplasm Metastasis 4Melanoma 4Fallopian Tube Neoplasms 4Stomach Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Neuroblastoma 3Glioma 3Carcinoma, Hepatocellular 3Urinary Bladder Neoplasms 2Salivary Gland Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2

Interventions

Doxorubicin 9Specimen Handling 7Sorafenib 7Erlotinib Hydrochloride 7Oxaliplatin 6Magnetic Resonance Spectroscopy 6Leucovorin 6Fluorouracil 5Thalidomide 4Radiofrequency Ablation 4Bevacizumab 4tremelimumab 3cediranib 3cabozantinib 3Trastuzumab 3Pharmacogenomic Testing 3Nivolumab 3Neoadjuvant Therapy 3Melphalan 3MK 2206 3Irinotecan 3Fluorodeoxyglucose F18 3Dasatinib 3Cisplatin 3Chemotherapy, Adjuvant 3Bortezomib 3Biopsy 3AZD 6244 3trametinib 2sargramostim 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NIH × Carcinoma, Hepatocellular × Chemotherapy, Adjuvant × Clear all
NCT00027768 2013-09-20

Radioactive Iodine in Treating Patients Who Have Undergone Surgery for Liver Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
300 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00276705 2013-09-17

Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
47 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00471484 2011-06-22

Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery

National Cancer Institute (NCI)

Phase 2 Unknown
54 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡